Metabolic improvement and abdominal fat redistribution in Werner syndrome by pioglitazone

J Am Geriatr Soc. 2004 Sep;52(9):1582-3. doi: 10.1111/j.1532-5415.2004.52430_4.x.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • Abdomen
  • Adipose Tissue / drug effects*
  • Body Constitution*
  • Female
  • Glucose / metabolism
  • Glucose Tolerance Test
  • Humans
  • Hyperlipidemias / genetics
  • Hyperlipidemias / metabolism
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use*
  • Insulin Resistance / physiology
  • Middle Aged
  • Pioglitazone
  • Thiazolidinediones / pharmacology
  • Thiazolidinediones / therapeutic use*
  • Treatment Outcome
  • Werner Syndrome* / drug therapy
  • Werner Syndrome* / genetics
  • Werner Syndrome* / metabolism

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones
  • Glucose
  • Pioglitazone